1. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse;Wang;Cancer Genet Cytogenet,2010
2. Is it important to decipher the heterogeneity of “normal karyotype AML”?;Nimer;Best Pract Res Clin Haematol,2008
3. [Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL) (2017)];Leukemia, Lymphoma Group CSoHCMA;Zhonghua Xue Ye Xue Za Zhi,2017
4. Acute myeloid leukemia: a comprehensive review and 2016 update;De Kouchkovsky;Blood Cancer J,2016
5. Breakthrough of the year 2013;Couzin-Frankel;Cancer immunotherapy Science,2013